Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Synopsys to Report Q1 Earnings: What's in the Cards for the Stock?
Synopsys to Report Q1 Earnings: What's in the Cards for the Stock?

Synopsys SNPS is scheduled to report first-quarter fiscal 2026 results on Feb. 25, after market close.

Synopsys expects non-GAAP earnings per share between $3.52 and $3.58. The Zacks Consensus

UAL Orders 300 GEnx Engines From GE Aerospace to Power Boeing 787s
UAL Orders 300 GEnx Engines From GE Aerospace to Power Boeing 787s

United Airlines UAL strengthened its long-term partnership with GE Aerospace GE by selecting 300 GEnx engines to power its new Boeing 787 Dreamliners. This order will expand UAL’s 787 fleet to more

The Zacks Analyst Blog Highlights Philip Morris, Lockheed Martin, Danaher and Zeo Energy
The Zacks Analyst Blog Highlights Philip Morris, Lockheed Martin, Danaher and Zeo Energy

For Immediate Release

Chicago, IL – February 23, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

NVIDIA Highlights This Week of Market Reportage
NVIDIA Highlights This Week of Market Reportage

Monday, February 23rd, 2026After a very eventful week for economic data and amount of Q4 earnings reports, we cool off some to stat a new trading week. We cap off “Mag 7” earnings with Wednesday

GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Beat Estimates
GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Beat Estimates

GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.7 per share a year ago

ImmunityBio (IBRX) Reports Q4 Loss, Beats Revenue Estimates
ImmunityBio (IBRX) Reports Q4 Loss, Beats Revenue Estimates

ImmunityBio (IBRX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.15 per share a year ago. These figures are

Stepan Co. (SCL) Reports Q4 Loss, Misses Revenue Estimates
Stepan Co. (SCL) Reports Q4 Loss, Misses Revenue Estimates

Stepan Co. (SCL) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.35. This compares to earnings of $0.12 per share a year ago. These figures are adjusted

Ivanhoe Electric (IE) Reports Q4 Loss, Tops Revenue Estimates
Ivanhoe Electric (IE) Reports Q4 Loss, Tops Revenue Estimates

Ivanhoe Electric (IE) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.19 per share a year ago. These figures

Lincoln Educational Services Corporation (LINC) Beats Q4 Earnings and Revenue Estimates
Lincoln Educational Services Corporation (LINC) Beats Q4 Earnings and Revenue Estimates

Lincoln Educational Services Corporation (LINC) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.31 per

Veris Residential (VRE) Q4 FFO and Revenues Top Estimates
Veris Residential (VRE) Q4 FFO and Revenues Top Estimates

Veris Residential (VRE) came out with quarterly funds from operations (FFO) of $0.19 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to FFO of $0.11 per share a

Dominion Energy (D) Q4 Earnings and Revenues Surpass Estimates
Dominion Energy (D) Q4 Earnings and Revenues Surpass Estimates

Dominion Energy (D) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.58 per share a year ago. These

Freightos Limited (CRGO) Reports Q4 Loss, Misses Revenue Estimates
Freightos Limited (CRGO) Reports Q4 Loss, Misses Revenue Estimates

Freightos Limited (CRGO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.2 per share a year ago. These figures

Freshpet (FRPT) Beats Q4 Earnings Estimates
Freshpet (FRPT) Beats Q4 Earnings Estimates

Freshpet (FRPT) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.36 per share a year ago. These figures

Domino's Pizza (DPZ) Lags Q4 Earnings Estimates
Domino's Pizza (DPZ) Lags Q4 Earnings Estimates

Domino's Pizza (DPZ) came out with quarterly earnings of $5.35 per share, missing the Zacks Consensus Estimate of $5.38 per share. This compares to earnings of $4.89 per share a year ago. These

AMC Entertainment (AMC) Reports Q4 Loss, Tops Revenue Estimates
AMC Entertainment (AMC) Reports Q4 Loss, Tops Revenue Estimates

AMC Entertainment (AMC) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.18 per share a year ago. These figures

Axsome Therapeutics (AXSM) Reports Q4 Loss, Tops Revenue Estimates
Axsome Therapeutics (AXSM) Reports Q4 Loss, Tops Revenue Estimates

Axsome Therapeutics (AXSM) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.7. This compares to a loss of $0.96 per share a year ago. These

Should You Buy ANI Pharmaceuticals Stock Before Q4 Earnings?
Should You Buy ANI Pharmaceuticals Stock Before Q4 Earnings?

ANI Pharmaceuticals ANIP is set to report fourth-quarter and full-year 2025 earningson Feb. 27, before the opening bell. The Zacks Consensus Estimate for the quarter’s sales and earnings is pegged

The Zacks Analyst Blog Highlights Taiwan Semiconductor, NVIDIA, Vertiv, Albemarle and Axsome Therapeutics
The Zacks Analyst Blog Highlights Taiwan Semiconductor, NVIDIA, Vertiv, Albemarle and Axsome Therapeutics

For Immediate Release

Chicago, IL – February 23, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Implied Volatility Surging for General Mills Stock Options
Implied Volatility Surging for General Mills Stock Options

Investors in General Mills, Inc. GIS need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $80.00 Call had some of the highest

Broadcom Shares Rise 60% in a Year: Is There More Room for Growth?
Broadcom Shares Rise 60% in a Year: Is There More Room for Growth?

Broadcom AVGO shares have jumped 60% in the trailing 12-month period, outperforming the broader Zacks Computer and Technology sector’s and the Zacks Electronics – Semiconductors industry’s return of

The Zacks Analyst Blog Highlights Blue Owl Capital, Apollo Global Management, Blackstone, KKR and Ares Management
The Zacks Analyst Blog Highlights Blue Owl Capital, Apollo Global Management, Blackstone, KKR and Ares Management

For Immediate Release

Chicago, IL – February 23, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Implied Volatility Surging for Warrior Met Coal Stock Options
Implied Volatility Surging for Warrior Met Coal Stock Options

Investors in Warrior Met Coal, Inc. HCC need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2026 $60.00 Call had some of the highest

Century Aluminum Q4 Earnings Miss Estimates, Decline Y/Y
Century Aluminum Q4 Earnings Miss Estimates, Decline Y/Y

Century Aluminum Company CENX reported earnings of 2 cents per share for the fourth quarter of 2025, missing the Zacks Consensus Estimate of $1.25. The figure compares unfavorably with the

Do Options Traders Know Something About Matador Resources Stock We Don't?
Do Options Traders Know Something About Matador Resources Stock We Don't?

Investors in Matador Resources Company MTDR need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $22.50 Put had some of the highest

The J. M. Smucker Q3 Earnings on Deck: Is a Beat Likely for SJM?
The J. M. Smucker Q3 Earnings on Deck: Is a Beat Likely for SJM?

The J. M. Smucker Company SJM is likely to witness top-line growth when it reports third-quarter fiscal 2026 earnings on Feb. 26. The Zacks Consensus Estimate for revenues is pegged at $2.3 billion